After the diagnosis of micro- or macroalbuminuria is confirmed, patients should undergo a complete evaluation, including a work-up for other etiologies and an assessment of renal function and the ...

Table 1. Diabetic Nephropathy Stages: Cutoff Values of Urine Albumin for Diagnosis and Main Clinical Characteristics Stages Albuminuria cutoff values (ref. 14) Clinical characteristics (ref. no.) ...

Panelists discuss how immunoglobulin A (IgA) nephropathy diagnosis requires kidney biopsy with immunofluorescence showing dominant or codominant IgA deposits in the mesangium, often accompanied by C3 ...

Pozzi C, Andrulli S, Pani A, et al. Addition of azathioprine to corticosteroids does not benefit patients with IgA nephropathy. J Am Soc Nephrol. 2010;21:1783-1790. Frisch G, Lin J, Rosenstock J, et ...

Immunoglobulin A (IgA) nephropathy is a rare autoimmune disorder that causes kidney damage and often leads to kidney failure. IgA nephropathy occurs when clumps of IgA get deposited in the kidneys, ...

Diabetes-related nephropathy is a potential complication of diabetes. Tests to help screen for nephropathy include urine protein tests, imaging tests, kidney biopsy, and glomerular filtration rate. A ...

It has been known for many decades that patients with IgA nephropathy who develop ESRD are at risk for re-developing IgA nephropathy in a renal transplant (recurrent IgA nephropathy). 1,39 Fortunately ...

Panelists discuss how diagnostic challenges in immunoglobulin A (IgA) nephropathy lead to delayed identification, missed treatment windows, and increased risk of irreversible kidney damage due to the ...

Balkan endemic nephropathy (BEN) is a chronic tubulointerstitial disease described only in some rural parts of southeastern Europe. One of its most peculiar characteristics is a strong association ...

Immunoglobulin A (IgA) nephropathy is an autoimmune condition that causes inflammation and damage in your kidneys, which may lead to kidney failure over time. IgA nephropathy develops when IgA builds ...

Sibeprenlimab, a monoclonal antibody, is the only IgA nephropathy treatment option to selectively inhibit the activity of a proliferation-inducing ligand (APRIL) to reduce IgA and galactose-deficient ...